Heparin 100U/L for Prevention of PVC Complications

PHASE3CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Peripheral Venous Catheter ComplicationsOcclusionPhlebitisEcchymosis
Interventions
OTHER

heparin 100U/L flushes

peripheral venous catheter flushing with 3 mL of a 100 U heparin/mL normal saline from mono-use vial (Epsodilave, Mayne Pharma, Naples, Italy) at the end of each drug infusion. Independently from the number of drug infusions, all patients will receive at least two catheter flushes every day.

Trial Locations (1)

27100

Medicina 3 - IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

NCT01131754 - Heparin 100U/L for Prevention of PVC Complications | Biotech Hunter | Biotech Hunter